Yoonjung Lee

Ms. Yoonjung Lee

University of Calgary
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2022 in Micromachines
Verified
Journal Article
Open access
PDF file
JSJaemyung Shin
Jaemyung Shin
YLYoonjung Lee
Yoonjung Lee
ZLZhangkang Li
Zhangkang Li
Jinguang HuJinguang Hu
Jinguang Hu
Simon ParkSimon Park
Simon Park
Keekyoung KimKeekyoung Kim
Keekyoung Kim
The need for organ transplants has risen, but the number of available organ donations for transplants has stagnated worldwide. Regenerative medicine has been developed to make natural organs or tissue-like structures with biocompatible materials and solve the donor shortage problem. Using biomaterials and embedded cells, a bioprinter enables the fabrication of complex and functional three-dimensional (3D) structures of the organs or tissues for regenerative medicine. Moreover, conventional surgical 3D models are made of rigid plastic or rubbers, preventing surgeons from interacting with real organ or tissue-like models. Thus, finding suitable biomaterials and printing methods will accelerate the printing of sophisticated organ structures and the development of realistic models to refine surgical techniques and tools before the surgery. In addition, printing parameters (e.g., printing speed, dispensing pressure, and nozzle diameter) considered in the bioprinting process should be optimized. Therefore, machine learning (ML) technology can be a powerful tool to optimize the numerous bioprinting parameters. Overall, this review paper is focused on various ideas on the ML applications of 3D printing and bioprinting to optimize parameters and procedures.

28 June 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NTNoah B. Toppings
Noah B. Toppings
AMAbu Naser Mohon
Abu Naser Mohon
YLYoonjung Lee
Yoonjung Lee
HKHitendra Kumar
Hitendra Kumar
DLDaniel Lee
Daniel Lee
DPDylan Pillai
Dylan Pillai
The highly infectious nature of SARS-CoV-2 necessitates the use of widespread testing to control the spread of the virus. Presently, the standard molecular testing method (reverse transcriptase-polymerase chain reaction, RT-PCR) is restricted to the laboratory, time-consuming, and costly. This increases the turnaround time for getting test results. This study sought to develop a rapid, near-patient saliva-based test for COVID-19 (Saliva-Dry LAMP) with similar accuracy to that of standard RT-PCR tests. A lyophilized dual-target reverse transcription-loop-mediated isothermal amplification (RT-LAMP) test with fluorometric detection by the naked eye was developed. The assay relies on dry reagents that are room temperature stable. A device containing a centrifuge, heat block, and blue LED light system was manufactured to reduce the cost of performing the assay. This test has a limit of detection of 1 copy/µL and achieved a positive percent agreement of 100% [95% CI 88.43% to 100.0%] and a negative percent agreement of 96.7% [95% CI 82.78–99.92%] relative to a reference standard test. Saliva-Dry LAMP can be completed in 105 min. Precision, cross-reactivity, and interfering substances analysis met international regulatory standards. The combination of ease of sample collection, dry reagents, visual detection, low capital equipment cost, and excellent analytical sensitivity make Saliva-Dry LAMP particularly useful for resource-limited settings.

8 September 2021 in Biomedical Engineering Letters
Verified
Journal Article
Closed access
PDF file
SHSetareh Homayoonnia
Setareh Homayoonnia
YLYoonjung Lee
Yoonjung Lee
DADaniyal Andalib
Daniyal Andalib
SRSazzadur Rahman
Sazzadur Rahman
JSJaemyung Shin
Jaemyung Shin
SKSeonghwan Kim
Seonghwan Kim